Logo image of IFX.CA

IMAFLEX INC (IFX.CA) Stock Fundamental Analysis

TSX-V:IFX - TSX Venture Exchange - CA4524352099 - Common Stock - Currency: CAD

1.42  +0.11 (+8.4%)

Fundamental Rating

5

IFX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 9 industry peers in the Containers & Packaging industry. IFX has an average financial health and profitability rating. IFX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year IFX was profitable.
In the past year IFX had a positive cash flow from operations.
Each year in the past 5 years IFX has been profitable.
In the past 5 years IFX always reported a positive cash flow from operatings.
IFX.CA Yearly Net Income VS EBIT VS OCF VS FCFIFX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M 15M

1.2 Ratios

IFX has a Return On Assets of 6.73%. This is comparable to the rest of the industry: IFX outperforms 55.56% of its industry peers.
The Return On Equity of IFX (9.13%) is comparable to the rest of the industry.
IFX has a Return On Invested Capital (8.51%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IFX is in line with the industry average of 8.97%.
Industry RankSector Rank
ROA 6.73%
ROE 9.13%
ROIC 8.51%
ROA(3y)8.73%
ROA(5y)8.16%
ROE(3y)12.01%
ROE(5y)11.77%
ROIC(3y)9.72%
ROIC(5y)10.2%
IFX.CA Yearly ROA, ROE, ROICIFX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

IFX has a Profit Margin of 5.33%. This is comparable to the rest of the industry: IFX outperforms 55.56% of its industry peers.
In the last couple of years the Profit Margin of IFX has declined.
With a Operating Margin value of 7.99%, IFX is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of IFX has declined.
IFX has a Gross Margin of 15.88%. This is in the lower half of the industry: IFX underperforms 77.78% of its industry peers.
IFX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.99%
PM (TTM) 5.33%
GM 15.88%
OM growth 3Y-33.68%
OM growth 5Y-8.52%
PM growth 3Y-57.98%
PM growth 5Y-33.28%
GM growth 3Y-14.95%
GM growth 5Y-1.16%
IFX.CA Yearly Profit, Operating, Gross MarginsIFX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so IFX is still creating some value.
The number of shares outstanding for IFX has been increased compared to 1 year ago.
The number of shares outstanding for IFX has been increased compared to 5 years ago.
Compared to 1 year ago, IFX has a worse debt to assets ratio.
IFX.CA Yearly Shares OutstandingIFX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
IFX.CA Yearly Total Debt VS Total AssetsIFX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

IFX has an Altman-Z score of 4.66. This indicates that IFX is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of IFX (4.66) is better than 77.78% of its industry peers.
The Debt to FCF ratio of IFX is 2.23, which is a good value as it means it would take IFX, 2.23 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of IFX (2.23) is better than 77.78% of its industry peers.
A Debt/Equity ratio of 0.12 indicates that IFX is not too dependend on debt financing.
IFX has a better Debt to Equity ratio (0.12) than 77.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 2.23
Altman-Z 4.66
ROIC/WACC1.15
WACC7.38%
IFX.CA Yearly LT Debt VS Equity VS FCFIFX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M

2.3 Liquidity

IFX has a Current Ratio of 2.85. This indicates that IFX is financially healthy and has no problem in meeting its short term obligations.
IFX's Current ratio of 2.85 is fine compared to the rest of the industry. IFX outperforms 77.78% of its industry peers.
IFX has a Quick Ratio of 1.76. This is a normal value and indicates that IFX is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of IFX (1.76) is better than 77.78% of its industry peers.
Industry RankSector Rank
Current Ratio 2.85
Quick Ratio 1.76
IFX.CA Yearly Current Assets VS Current LiabilitesIFX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

6

3. Growth

3.1 Past

IFX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 183.95%, which is quite impressive.
The earnings per share for IFX have been decreasing by -32.44% on average. This is quite bad
The Revenue has grown by 16.56% in the past year. This is quite good.
IFX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.63% yearly.
EPS 1Y (TTM)183.95%
EPS 3Y-57.25%
EPS 5Y-32.44%
EPS Q2Q%848.48%
Revenue 1Y (TTM)16.56%
Revenue growth 3Y2.59%
Revenue growth 5Y1.63%
Sales Q2Q%24.32%

3.2 Future

IFX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.10% yearly.
IFX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.71% yearly.
EPS Next Y0%
EPS Next 2Y29.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.2%
Revenue Next 2Y5.71%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IFX.CA Yearly Revenue VS EstimatesIFX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
IFX.CA Yearly EPS VS EstimatesIFX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.05 0.1 0.15 0.2

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 12.91, IFX is valued correctly.
66.67% of the companies in the same industry are more expensive than IFX, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 29.63, IFX is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 27.57, the valuation of IFX can be described as expensive.
Based on the Price/Forward Earnings ratio, IFX is valued a bit more expensive than 77.78% of the companies in the same industry.
IFX's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 22.68.
Industry RankSector Rank
PE 12.91
Fwd PE 27.57
IFX.CA Price Earnings VS Forward Price EarningsIFX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

66.67% of the companies in the same industry are more expensive than IFX, based on the Enterprise Value to EBITDA ratio.
IFX's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 15.7
EV/EBITDA 5.8
IFX.CA Per share dataIFX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

IFX's earnings are expected to grow with 29.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.1%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for IFX!.
Industry RankSector Rank
Dividend Yield N/A

IMAFLEX INC

TSX-V:IFX (2/20/2025, 7:00:00 PM)

1.42

+0.11 (+8.4%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)11-27 2024-11-27
Earnings (Next)04-24 2025-04-24
Inst Owners10.17%
Inst Owner ChangeN/A
Ins Owners46.47%
Ins Owner ChangeN/A
Market Cap73.97M
Analysts84.44
Price Target1.02 (-28.17%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 12.91
Fwd PE 27.57
P/S 0.69
P/FCF 15.7
P/OCF 6.07
P/B 1.18
P/tB 1.22
EV/EBITDA 5.8
EPS(TTM)0.11
EY7.75%
EPS(NY)0.05
Fwd EY3.63%
FCF(TTM)0.09
FCFY6.37%
OCF(TTM)0.23
OCFY16.48%
SpS2.07
BVpS1.21
TBVpS1.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.73%
ROE 9.13%
ROCE 11.72%
ROIC 8.51%
ROICexc 8.96%
ROICexgc 9.27%
OM 7.99%
PM (TTM) 5.33%
GM 15.88%
FCFM 4.38%
ROA(3y)8.73%
ROA(5y)8.16%
ROE(3y)12.01%
ROE(5y)11.77%
ROIC(3y)9.72%
ROIC(5y)10.2%
ROICexc(3y)11.16%
ROICexc(5y)11.31%
ROICexgc(3y)11.62%
ROICexgc(5y)11.76%
ROCE(3y)13.98%
ROCE(5y)14.61%
ROICexcg growth 3Y-42.05%
ROICexcg growth 5Y-15.01%
ROICexc growth 3Y-41.96%
ROICexc growth 5Y-15.04%
OM growth 3Y-33.68%
OM growth 5Y-8.52%
PM growth 3Y-57.98%
PM growth 5Y-33.28%
GM growth 3Y-14.95%
GM growth 5Y-1.16%
F-Score7
Asset Turnover1.26
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 2.23
Debt/EBITDA 0.56
Cap/Depr 140.21%
Cap/Sales 6.95%
Interest Coverage 10.83
Cash Conversion 87.45%
Profit Quality 82.04%
Current Ratio 2.85
Quick Ratio 1.76
Altman-Z 4.66
F-Score7
WACC7.38%
ROIC/WACC1.15
Cap/Depr(3y)233.61%
Cap/Depr(5y)181.89%
Cap/Sales(3y)9.77%
Cap/Sales(5y)7.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)183.95%
EPS 3Y-57.25%
EPS 5Y-32.44%
EPS Q2Q%848.48%
EPS Next Y0%
EPS Next 2Y29.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.56%
Revenue growth 3Y2.59%
Revenue growth 5Y1.63%
Sales Q2Q%24.32%
Revenue Next Year4.2%
Revenue Next 2Y5.71%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y140.79%
EBIT growth 3Y-31.96%
EBIT growth 5Y-7.03%
EBIT Next Year160.41%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y44.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.65%
OCF growth 3Y-23.08%
OCF growth 5Y36.85%